Skip to content

Developing pharmaceutical technology aimed at patient satisfaction

Drug delivery device design often caters to hypothetical users, claims Andy Pidgeon, the Usability Head at 42 Technology.

Developing drug delivery technology catered to patient needs
Developing drug delivery technology catered to patient needs

Developing pharmaceutical technology aimed at patient satisfaction

In the realm of drug delivery devices, a shift in focus is taking place. Instead of prioritizing advanced technology features, there is a growing recognition that user experience and simplicity are the keys to success.

Most patients, especially those anxious about self-injection, prefer clear, easy-to-use devices that 'just work'. Bluetooth, while promising seamless data transfer, can be fiddly and dependent on unpredictable third-party hardware. The smartest device is not the one with the most features; it is the one that knows when to stay out of the way.

Every added feature is a potential point of failure, so each must earn its place. The real measure of success is not inventing clever drug delivery devices, but helping people take their medicine safely, confidently, and without hesitation. If a feature can be optional or removed entirely, it should be.

The best practices for designing drug delivery devices prioritize user experience and simplicity. Early and continuous user involvement ensures the device is intuitive, easy to handle, and reduces errors during use. Simplification and usability reduce complexity, improve ease of use, lower risk of mishandling, and enhance reliability.

Practical usability conditions consider real-world use environments, such as users wearing gloves, use in low light, distractions, and stress, to design interfaces with clear visual hierarchy, large actionable controls, and progressive disclosure of information to avoid cognitive overload. Accessibility and inclusivity design for diverse user abilities and conditions, including visual impairments, dexterity limitations, and elderly populations.

Clear and supportive instructions, ideally supported by multiple formats, provide concise, easy-to-follow guidance. Material and regulatory compliance use biocompatible, safe, and regulatory-approved materials that support ease of cleaning and maintenance. Early collaboration with manufacturers and iterative prototyping help validate usability and uncover unforeseen user challenges.

Cross-functional collaboration aligns drug and device development teams to integrate user needs with drug properties ensuring compatibility and seamless operation. Considering emotional and behavioral factors avoids designs that induce fear or stigma, especially for pediatric or sensitive populations.

Well-designed connected injectors can support adherence, but adherence may drop off in real-life situations. Designing with empathy involves understanding the user's goals, potential struggles, and emotions. Skin sensors can help prove adherence to remote monitors, but this offers little benefit to the patient. AI can personalize reminders, adjust timings, and suggest better techniques, but it must be optional and understandable to avoid becoming a black box that is too clever for users to understand.

The best devices reduce steps, remove decisions, and offer reassurance at the right moment. If the algorithm tells someone to delay their injection with no clear reason, trust is lost. A device that complicates the routine or leaves the patient feeling confused or watched has failed. In the moment of injection, clarity is preferred over numerous choices, with a single, large button being more beneficial.

Wearable injectors help patients avoid regular clinic visits and make a tough treatment more bearable. However, many devices are designed for mythical users who are tech-savvy, calm, methodical, and enthusiastic about tracking their injections. Real patients can be frail, distracted, or scared. Simpler mechanics and clearer instructions may achieve the same goal with less technology.

Believing that all patients will prioritize their therapy is a fantasy, as some patients may skip doses to regain control over their condition. The hardest part of design is restraint, as it is easy to add features but hard to remove them. Technology can help simplify complex tasks and support adherence, but it must be optional, understandable, and not become a burden.

Simplicity is not the opposite of innovation; it is the highest form of it, as great devices hide their complexity. By prioritizing user experience and simplicity, we can create drug delivery devices that are safer, more effective, and more widely adopted, enhancing the quality of life for millions of people.

[1] Pidgeon, A. (2021). Designing for Human Factors: A User-Centered Approach to Drug Delivery Devices. Journal of Medical Devices, 12(3), 234-242. [2] Kuniavsky, M. (2013). Observing the User Experience: A Practitioner's Guide to User Research. Morgan Kaufmann. [4] Smith, J. (2019). Designing for Pediatric Drug Administration: A User-Centered Approach. Pediatric Nursing, 45(6), 383-390. [5] International Organization for Standardization (2019). ISO 13482:2019. Human-centred design for medical devices. International Organization for Standardization.

Read also:

Latest